Group 1 - The core point of the article is that Chutian Technology Co., Ltd. is issuing convertible bonds worth up to RMB 1 billion to unspecified investors, with the aim of raising funds for specific projects and working capital [2][19][21] - The convertible bonds will have a term of six years, with an annual interest rate that increases from 0.30% in the first year to 2.00% in the sixth year [3][4] - The initial conversion price for the bonds is set at RMB 10.00 per share, which is subject to adjustments based on various corporate actions [6][8] Group 2 - The company reported a revenue of RMB 582.98 million for the reporting period, a decrease of 14.94% compared to the previous year, primarily due to a slowdown in domestic market demand and increased competition [25][26] - The net profit attributable to the parent company showed a significant decline, with a loss of RMB 49.31 million, representing a 259.33% decrease year-on-year [26][28] - The company is actively expanding its international market presence, achieving a 13.70% increase in international sales revenue, which reached RMB 213.85 million [25][26]

1 联合〔2025〕5123 号 联合资信评估股份有限公司通过对楚天科技股份有限公司主体 及其相关债券的信用状况进行跟踪分析和评估，确定维持楚天科技 股份有限公司主体长期信用等级为 AA，维持"楚天转债"信用等级 为 AA，评级展望为稳定。 特此公告 楚天科技股份有限公司 向不特定对象发行可转换公司债券 2025 年跟踪评级报告 www.lhratings.com 联合资信评估股份有限公司 评级总监： 二〇二五年六月二十四日 跟踪评级报告 | 2 声 明 一、本报告是联合资信基于评级方法和评级程序得出的截至发表之日的 独立意见陈述，未受任何机构或个人影响。评级结论及相关分析为联合资信基 于相关信息和资料对评级对象所发表的前瞻性观点，而非对评级对象的事实 陈述或鉴证意见。联合资信有充分理由保证所出具的评级报告遵循了真实、客 观、公正的原则。鉴于信用评级工作特性及受客观条件影响，本报告在资料信 息获取、评级方法与模型、未来事项预测评估等方面存在局限性。 二、本报告系联合资信接受楚天科技股份有限公司（以下简称"该公 司"）委托所出具，除因本次评级事项联合资信与该公司构成评级委托关系 外，联合资信、评级人员与该公司不 ...

债券简称：楚天转债 债券代码：123240.SZ 楚天科技股份有限公司 （湖南省长沙市宁乡市玉潭镇新康路 1 号） 债券受托管理人 国金证券股份有限公司 关于楚天科技股份有限公司 向不特定对象发行可转换公司债券 受托管理事务报告 （2024 年度） 发行人 （住所：成都市青羊区东城根上街 95 号） 2025 年 6 月 1 声明 根据《可转换公司债券管理办法》、《公司债券受托管理人执业行为准则（2023 年修订）》、交易所关于定期受托管理事务报告的规定要求，以及相关债券受托管 理协议、募集说明书等相关约定，国金证券股份有限公司（以下简称"国金证券"） 作为受托管理人，以公开信息披露文件、发行人出具的相关说明文件以及第三方 中介机构出具的专业意见等为信息来源编制本定期受托管理事务报告。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜做出独立判断，而不应将本报告中的任何内容据以作为国金证券所作的承诺 或声明。未经国金证券书面许可，不得将本报告用作其他任何用途。 2 | 声明 2 | | | --- | --- | | 目录 3 | | | 第一章 | 本次可转债基本情况 4 | | 一 ...

Summary of Key Points Core Viewpoint - Chutian Technology Co., Ltd. has successfully completed its obligation to repurchase equity from the National Development Fund for its subsidiary, Chutian Intelligent Robot (Changsha) Co., Ltd., and has fully released its guarantee obligations to Ningxiang Economic Development Group [1][4]. Group 1: Guarantee Overview - Chutian Technology provided a counter-guarantee for Ningxiang Economic Development Group, which was a third-party guarantee for a 60 million yuan investment from the National Development Fund to Chutian Intelligent Robot [1]. - The guarantee was secured by the company's own land and properties located in Changsha, with a total guarantee amount of 60 million yuan and a term of 15 years [1]. Group 2: Guarantee Progress - As of the announcement date, the company has completed the repurchase of all equity from the National Development Fund, making Chutian Robot a wholly-owned subsidiary [4]. - The company has fully released its counter-guarantee responsibilities to Ningxiang Economic Development Group, and there are no remaining guarantee obligations [4]. Group 3: Other Information - The actual guarantee balance of the company is 927.74 million yuan, which accounts for 6.97% of the company's audited total assets and net assets for the year 2024 [4].

| 证券代码：300358 | 证券简称：楚天科技 | 公告编号：2025-042 | 号 | | --- | --- | --- | --- | | 债券代码：123240 | 债券简称：楚天转债 | | | 楚天科技股份有限公司 关于公司对外担保进展暨解除对外担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、对外担保情况概述 楚天科技股份有限公司（以下简称"楚天科技""公司"）于 2016 年 3 月 3 日召开第二届董事会第二十三次会议，审议通过了《关于公司为长沙蓝月谷实业 集团有限公司提供反担保的议案》。国开发展基金有限公司（以下简称"国开发 展基金"）为楚天科技子公司楚天智能机器人（长沙）有限公司（以下简称"楚 天机器人"）以增资方式提供 6000 万元资金支持，期限 15 年。楚天科技对该笔 增资形式的股权提供回购承诺，并委托长沙蓝月谷实业集团有限公司（现更名为： 宁乡经开区实业集团有限公司，以下简称"宁乡经开实业集团"）为上述回购 及国开发展基金每年的投资收益提供第三方连带责任保证担保。公司以位于长沙 市宁乡县楚天科技工业园内的自有 ...

Core Viewpoint - The company is actively expanding its international market presence and has established localized sales and service networks in over ten key countries and regions, aiming to enhance its global competitiveness and brand influence in the pharmaceutical equipment sector [1][4]. Group 1: International Market Expansion - The company has strategically divided its global operations into five regional departments to strengthen its international sales and service capabilities [1]. - In 2024, the company expects to achieve over 1.2 billion in new export orders, with products entering high-end markets such as Europe [1][4]. - Major international pharmaceutical companies have initiated supplier audits for the company, indicating potential future collaborations [1]. Group 2: Order Delivery and Revenue Recognition - The manufacturing cycle for main products typically ranges from 3 to 9 months, with revenue recognition based on specific criteria for domestic and international orders [2]. - The impact of U.S. tariffs on the company's sales and supply chain is minimal, as exports to the U.S. constitute a small portion of overall revenue [2]. Group 3: Development in Specific Fields - The company has established a joint venture in the peptide synthesis equipment sector, with the subsidiary achieving sales and reporting total assets of approximately 15.61 million and a net loss of about 2.22 million for 2024 [3]. - The company is pioneering the development of smart pharmaceutical factories, focusing on integrating artificial intelligence into its production processes to enhance efficiency and user value [3].

Group 1: International Market Expansion - The company has established localized sales and service networks in over 10 key countries and regions, enhancing its international business localization strategy [2] - In 2024, the company achieved new export orders exceeding 1.2 billion, with products entering high-end markets in Europe [2] - The company has divided its global market into five regional departments to strengthen international sales and service responsiveness [2] Group 2: Order Delivery and Revenue Recognition - The manufacturing cycle for main products typically ranges from 3 to 9 months, with revenue recognition based on customer acceptance [3] - For domestic orders, revenue is recognized upon obtaining the customer's signed acceptance, while for international orders, it is recognized upon receipt of customs and shipping documents [3] Group 3: Impact of Tariffs and Supply Chain - The impact of U.S. tariffs on the company's sales is minimal, as exports to the U.S. constitute a very small portion of overall revenue [3] - The company has invested in self-research for core components, reducing reliance on U.S. imports, and can substitute with domestic or other imported brands [3] Group 4: Development in Peptide Field - In August 2023, the company established a joint venture in peptide synthesis equipment, with total assets of approximately 15.6 million and a net profit of about 5.3 million by the end of 2024 [3] Group 5: AI Integration in Business - The company is leading the pharmaceutical equipment industry in developing smart pharmaceutical factories, focusing on both hardware and software investments [3] - The strategy aims to enhance production capabilities through AI technology, improving user value [3]

证券代码：300358 证券简称：楚天科技 公告编号：2025-041 号 债券代码：123240 债券简称：楚天转债 楚天科技股份有限公司 关于完成董事会换届选举及聘任高级管理人员、财务总 监、董事会秘书、内审负责人、证券事务代表的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 楚天科技股份有限公司（以下简称"楚天科技""公司"）2025 年 5 月 29 日 召开 2024 年年度股东大会，审议通过了关于董事会换届选举的相关议案。本次 选举产生了 8 名非独立董事、5 名独立董事，与公司通过职工代表大会选举产生 的 1 名职工代表董事，共同组成公司第六届董事会。任职期限至本次股东会通过 之日起三年。 同日，公司召开第六届董事会第一次会议，审议通过了《关于选举公司第六 届董事会董事长、副董事长的议案》、《关于选举公司第六届董事会专门委员会委 员的议案》、《关于聘任公司高级管理人员的议案》、《关于聘任公司财务总监、董 事会秘书、内审负责人、证券事务代表的议案》。现将有关情况公告如下： 一、董事会换届选举情况 （一）董事选举情况 公司于 2025 年 5 ...

法律意见书 湖南启元律师事务所 关于楚天科技股份有限公司 2024年年度股东大会的 致：楚天科技股份有限公司 湖南启元律师事务所（以下简称"本所"）接受楚天科技股份有限公司（以下 简称"公司"）的委托，指派本所律师列席了公司 2024 年年度股东大会（以下简 称"本次股东大会"），对本次股东大会的召集和召开程序、出席会议人员及召集 人的资格、表决程序和表决结果的合法有效性进行现场律师见证，并发表本法律 意见。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以下简称"《股 东会规则》"）、《深圳证券交易所上市公司股东会网络投票实施细则（2025 年修订）》 等我国现行法律、法规、规范性文件以及《楚天科技股份有限公司章程》（以下简 称"《公司章程》"）的有关规定出具本法律意见。 本所律师声明如下： （一）本所律师根据本法律意见书出具日以前已经发生或者存在的事实，严 格履行了法定职责，遵循了勤勉尽责和诚实信用原则，进行了充分的核查验证， 保证本法律意见所认定的事实真实、准确、完整，所发表的结论性意见合法、准 确，不存在虚 ...

| 证券代码：300358 | 证券简称：楚天科技 公告编号：2025-039 号 | | --- | --- | | 债券代码：123240 | 债券简称：楚天转债 | 楚天科技股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会以现场投票和网络投票相结合的方式召开。 2、2025 年 4 月 29 日公司披露了《关于召开 2024 年年度股东大会的通知》，本次 股东大会无新增、更改、否决议案的情况。 3、本次股东大会议案 8、10 为特别决议事项，应由出席股东大会的股东（包括股 东代理人）所持表决权的 2/3 以上审议通过。议案 12、13 为累积投票提案。 4、为尊重中小投资者利益，提高中小投资者对公司股东大会决议的重大事项的参 与度，本次股东大会审议影响中小投资者利益的重大事项时对中小投资者的表决单独 计票，中小投资者指单独或者合计持有本公司 5%以上股份的股东以外的其他股东，且 不包括持有公司股份的董事、监事和高级管理人员。 一、会议召开及出席情况 1、会议召集人：公司董事会 2 ...